Cogstate Limited (COGZF)

Market Cap	263.53M +70.9%
Revenue (ttm)	56.07M +18.8%
Net Income	10.78M +46.7%
EPS	0.06 +44.6%
Shares Out	n/a
PE Ratio	24.46
Forward PE	20.86
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,400
Average Volume	2,355
Open	1.500
Previous Close	n/a
Day's Range	1.500 - 1.500
52-Week Range	0.816 - 2.100
Beta	-0.02
RSI	47.75
Earnings Date	Feb 19, 2026

About Cogstate

Cogstate Limited, a neuroscience solutions company, engages in the creation, validation, and commercialization of digital brain health assessments worldwide. It offers digital cognitive assessment, endpoint data quality (rater services), remote assessment, scientific consulting, healthcare cognitive screening, and research and academic collaboration solutions for various therapeutic areas, including Alzheimer’s disease and dementia, preclinical Alzheimer’s disease, pediatrics and rare disease, Parkinson’s disease, multiple sclerosis, schizophre...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1999
• Employees: 160
• Stock Exchange: OTCMKTS
• Ticker Symbol: COGZF

Financial Performance

In fiscal year 2025, Cogstate's revenue was $53.09 million, an increase of 22.25% compared to the previous year's $43.43 million. Earnings were $10.14 million, an increase of 86.15%.